ES424882A1 - Vinca alkaloid derivatives - Google Patents

Vinca alkaloid derivatives

Info

Publication number
ES424882A1
ES424882A1 ES424882A ES424882A ES424882A1 ES 424882 A1 ES424882 A1 ES 424882A1 ES 424882 A ES424882 A ES 424882A ES 424882 A ES424882 A ES 424882A ES 424882 A1 ES424882 A1 ES 424882A1
Authority
ES
Spain
Prior art keywords
hydrogen
formula
acetyl
compound
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES424882A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES424882A1 publication Critical patent/ES424882A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A process for the preparation of vinblastine, leurosine and leurocristine derivatives: ** formula ** or its pharmaceutically acceptable acid addition salts, where R is NH2, NH-NH2, NH-C2H5 or NH-CH3; R'' is hydrogen or acetyl, R''` is hydrogen, (C1-C3) alkyl, formyl or (C1-C3) alkanolyl, and one of the radicals R''``'' or R''``''`` it is hydroxyl and the other is ethyl; whose process is characterized by reacting a compound of Formula I where R is O-CH3, R'' is hydrogen or acetyl and R''`, R''``'' and R''``'' are those defined above, with a compound of formula NH2R1, where R1 is H, CH3, C2H5 or NH2 and, if desired, react any of the products obtained above with an organic or inorganic, non-toxic acid to form the acid addition salt of the product. (Machine-translation by Google Translate, not legally binding)
ES424882A 1973-04-02 1974-04-02 Vinca alkaloid derivatives Expired ES424882A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34727573A 1973-04-02 1973-04-02

Publications (1)

Publication Number Publication Date
ES424882A1 true ES424882A1 (en) 1976-12-16

Family

ID=23363051

Family Applications (2)

Application Number Title Priority Date Filing Date
ES424882A Expired ES424882A1 (en) 1973-04-02 1974-04-02 Vinca alkaloid derivatives
ES446571A Expired ES446571A1 (en) 1973-04-02 1976-03-31 Vinca alkaloid derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES446571A Expired ES446571A1 (en) 1973-04-02 1976-03-31 Vinca alkaloid derivatives

Country Status (28)

Country Link
JP (2) JPS5919117B2 (en)
AR (2) AR204004A1 (en)
AT (1) AT340605B (en)
BE (1) BE813168A (en)
BG (3) BG21612A3 (en)
CA (1) CA1042428A (en)
CH (1) CH603669A5 (en)
CS (1) CS185223B2 (en)
CY (1) CY1044A (en)
DD (1) DD113538A5 (en)
DE (1) DE2415980A1 (en)
DK (1) DK141511B (en)
ES (2) ES424882A1 (en)
FR (1) FR2223044B1 (en)
GB (1) GB1463575A (en)
HK (1) HK20180A (en)
HU (1) HU171572B (en)
IE (1) IE39071B1 (en)
IL (1) IL44415A (en)
KE (1) KE3028A (en)
MY (1) MY8100025A (en)
NL (1) NL181079C (en)
PH (1) PH13623A (en)
RO (2) RO77533A (en)
SE (1) SE416206B (en)
SU (4) SU731900A3 (en)
YU (3) YU39719B (en)
ZA (1) ZA741674B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
GR69783B (en) * 1976-09-08 1982-07-07 Lilly Co Eli
USRE30560E (en) * 1976-12-06 1981-03-31 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates
US4203898A (en) 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4199504A (en) * 1978-05-15 1980-04-22 Eli Lilly And Company Bridged cathranthus alkaloid dimers
US4357334A (en) 1980-03-20 1982-11-02 Eli Lilly And Company Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms
OA06421A (en) * 1980-06-10 1981-09-30 Omnium Chimique Sa Process for the preparation of N- (vinblastinoyl-23) derivatives of amino acids and peptides.
LU83822A1 (en) 1981-12-08 1983-09-01 Omnichem Sa N- (VINBLASTINOYL-23) DERIVATIVES OF AMINO ACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2623504B1 (en) * 1987-11-25 1990-03-09 Adir NOVEL N- (VINBLASTINOYL-23) DERIVATIVES OF 1-AMINO METHYLPHOSPHONIC ACID, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUT76925A (en) * 1995-04-04 1998-01-28 MTA Enzimológiai Intézet Bis-indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6326402B1 (en) 1998-08-12 2001-12-04 Octamer, Inc. Methods for treating viral infections using a compound capable of inhibiting microtubules
CA2594474C (en) 2005-01-21 2016-03-29 Astex Therapeutics Limited Pharmaceutical compounds
CN101242822B (en) 2005-07-18 2011-08-24 彼帕科学公司 Medicine of ovarian cancer
JP2010502730A (en) 2006-09-05 2010-01-28 バイパー サイエンシズ,インコーポレイティド Cancer treatment
CN101534836B (en) 2006-09-05 2011-09-28 彼帕科学公司 Use of PARP inhibition in preparing medicine for obesity
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
WO2009064738A2 (en) 2007-11-12 2009-05-22 Bipar Sciences, Inc. Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents
EP2987794B1 (en) * 2013-04-19 2018-05-30 Jinan University Vinblastine derivatives, preparation method therefor and application thereof
CN113456797B (en) * 2021-06-18 2024-03-08 暨南大学 Application of vinblastine derivatives in preparation of medicines for treating osteosarcoma and/or soft tissue sarcoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine

Also Published As

Publication number Publication date
SU784783A3 (en) 1980-11-30
CY1044A (en) 1980-08-01
JPS59193895A (en) 1984-11-02
FR2223044A1 (en) 1974-10-25
YU39719B (en) 1985-04-30
RO77533A (en) 1982-02-01
SU731900A3 (en) 1980-04-30
AR203882A1 (en) 1975-10-31
DE2415980A1 (en) 1974-10-10
NL7404423A (en) 1974-10-04
JPS49128000A (en) 1974-12-07
BG21235A3 (en) 1976-03-20
SU652896A3 (en) 1979-03-15
ATA267974A (en) 1977-04-15
DK141511B (en) 1980-04-08
AT340605B (en) 1977-12-27
YU39875B (en) 1985-04-30
NL181079C (en) 1987-06-16
BE813168A (en) 1974-10-02
RO73524A (en) 1984-10-31
IE39071B1 (en) 1978-08-02
PH13623A (en) 1980-08-07
FR2223044B1 (en) 1978-06-30
YU113880A (en) 1982-05-31
KE3028A (en) 1980-03-28
ES446571A1 (en) 1977-06-16
HK20180A (en) 1980-04-25
AU6671974A (en) 1975-09-18
YU81774A (en) 1982-05-31
AR204004A1 (en) 1975-11-12
CA1042428A (en) 1978-11-14
GB1463575A (en) 1977-02-02
CS185223B2 (en) 1978-09-15
NL181079B (en) 1987-01-16
ZA741674B (en) 1975-10-29
DE2415980C2 (en) 1989-11-09
IL44415A0 (en) 1974-06-30
MY8100025A (en) 1981-12-31
IE39071L (en) 1974-10-02
DK141511C (en) 1980-09-29
YU113980A (en) 1982-05-31
RO73524B (en) 1984-11-30
CH603669A5 (en) 1978-08-31
HU171572B (en) 1978-02-28
SU623522A3 (en) 1978-09-05
SE416206B (en) 1980-12-08
BG21612A3 (en) 1976-07-20
JPS6033837B2 (en) 1985-08-05
YU39876B (en) 1985-04-30
DD113538A5 (en) 1975-06-12
BG22831A3 (en) 1977-04-20
IL44415A (en) 1978-08-31
JPS5919117B2 (en) 1984-05-02

Similar Documents

Publication Publication Date Title
ES424882A1 (en) Vinca alkaloid derivatives
IE41528L (en) Furfuryl-benzomorphane derivatives.
ES394370A1 (en) Pharmacologically active 3-piperazinyl-carbonyloxy-2-pyridyl-isoindolin-1-ones
ES439909A1 (en) 2-thiol-4,5-diphenyloxazole s-derivatives
ES411038A1 (en) Substituted azetidinones
ES404744A1 (en) Cephalosporin derivatives
SE7710059L (en) PROCEDURE FOR THE PREPARATION OF AMIDDERIVATED WINE BLASTIN, OF LEUROSIDINE, LEUROCRISTINE AND RELATED DIMERA ALKALOIDS
ES413960A1 (en) Manufacture of novel propylene-diamine derivative
ES438704A1 (en) Ergot peptide alkaloids
ES423699A1 (en) 3-oxyiminomethyl-cephalosporins
ES433132A1 (en) Derivatives of 1-phenoxy-3-aminopropan-2-ol and processes for their preparation
ES371373A1 (en) Procedure for the obtaining of substitute 4-oxo-3-amino-3,4-dihydrotean (3,2-d) pyrimidine derivatives. (Machine-translation by Google Translate, not legally binding)
ES419142A1 (en) 2-2-2-methyl-5-nitro-1-imidazolyl-ethyl-2-thiopseudoureas and related compounds
ES410855A1 (en) Process for the production of benzocycloheptathiophenone derivative
ES395958A1 (en) Hydroxyaryl amino acids
ES391493A1 (en) P'-alkoxy-ergotamines
ES452391A1 (en) Benzisothiazoline-1,1-dioxide derivatives, compositions and methods
ES441029A1 (en) Acetylsalicylic acid derivatives their preparation and compo sitions containing them
ES393554A1 (en) Thiazole derivatives and a process for the manufacture thereof
ES405080A1 (en) Bis-(para-chlorophenoxy)carbinol and ethers thereof
ES414340A1 (en) Piperazine derivatives
ES444483A1 (en) A procedure for the preparation of new derivatives of acid2,3-alquilen (lower) penam-3-carboxylic. (Machine-translation by Google Translate, not legally binding)
ES450876A1 (en) Pyrido (3,4-b)indole derivatives
ES411184A1 (en) Alpha-carboxy-2-thienylmethylpenicillin and cephalosporin and esters and salts thereof
ES395414A1 (en) 1,2,4-benzothiadiazine-1,1-dioxide derivatives